Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-a

被引:1
作者
Kazutaka Kurokohchi
Kouichi Takaguchi
Keiji Kita
Tsutomu Masaki
Shigeki Kuriyama
机构
[1] Department of Internal Medicine Kagawa Prefectural Central Hospital 5-4-16 Ban-cho Takamatsu Kagawa 760-8557 Japan
[2] Third Department of Internal Medicine Kagawa University School of Medicine 1750-1 Ikenobe Miki-cho Kita-gun Kagawa 761-0793 Japan
[3] Third Department of Internal Medicine Kagawa University School of Medicine 1750-1 Ikenobe Miki-cho Kita-gun Kagawa 761-0793 Japan
关键词
Hepatocellular carcinoma; 5-Fluorouracil; Pegylated interferon-α; Combination therapy;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
We report a case of hepatocellular carcinoma (HCC) treated successfully by transarterial chemoembolization (TACE) followed by combination therapy of 5-fluorouracil (5-FU) and pegylated interferon-α (PEG-IFN-α). In the present case, the patient had massive and advanced HCC with a diameter of over 8 cm located in segment 7 (S7) of the liver. Furthermore, the tumor invaded into the major branch of the portal vein (Vp3). After TACE, combined administration of 5-FU and PEG-IFN-α was performed for 5 mo. HCC was totally eradicated and the serum levels of tumor markers were markedly decreased by the treatment. Although it has been reported that the combined use of conventional IFN-a and 5-FU showed striking effects on HCC in some cases, this case may suggest the more promising effect of PEG-IFN-α with a long-lasting effect, in the combined use with 5-FU for the treatment of massive advanced HCC.
引用
收藏
页码:5401 / 5403
页数:3
相关论文
共 2 条
[1]  
Phase III trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. Patt YZ,Hassen MM,Lozano RD,Brown TD,Vauthey JN,Curley SA,Elliis LM. Journal of Clinical Oncology . 2003
[2]   Cancer [P]. 
英国专利 :GB0005466D0 ,2000-04-26